In healthcare, performance is often measured through dashboards filled with averages, benchmarks, and utilization rates. But for patients, performance feels very different. It’s measured in days. Sometimes weeks. And always in uncertainty.
Time to treatment—the space between a referral and the start of therapy
is the most honest indicator of how well a clinical workflow is functioning.
Not because speed alone guarantees better outcomes, but because delays almost always reveal deeper issues: fragmented workflows, inconsistent processes, disconnected technology, and misaligned teams.
In Healthcare, performance is often measured through dashboards filled with averages, benchmarks, and utilization rates. But for patients, performance feels very different. It’s measured in days. Sometimes weeks. And always in uncertainty. Time to treatment—the space between a referral and the start of therapy is the most honest indicator of how well an oncology system is functioning. Not because speed alone guarantees better outcomes, but because delays almost always reveal deeper issues: fragmented workflows, inconsistent processes, disconnected technology, and misaligned teams.
For patients, time to treatment is not a metric. It’s the waiting period between knowing something is wrong and knowing something is being done. That waiting period can fill up quickly with administrative handoffs, incomplete referrals, prior authorization delays, scheduling bottlenecks, and unclear ownership across teams.
For care teams, long time to treatment often signals operational friction rather than clinical complexity. Most delays are not caused by medical indecision—they are caused by process breakdowns.
When time to treatment stretches, it usually points to one or more system-level problems:
Time to treatment captures all of this in a single, patient-centered outcome.
There’s a misconception that reducing time to treatment means rushing decisions or
compromising quality. In reality, the opposite is true.
The organizations that move patients to treatment faster do so by:
Speed comes from clarity, standardization, and reliability, not pressure.
As healthcare becomes more complex, with more modalities, more data, and more coordination required, the systems that succeed will be the ones that can translate clinical intent into operational reality.
Time to treatment reflects whether that translation is working.
At Cyan Healthcare Group, we focus on time to treatment because it aligns everyone—clinical, operational, and executive—around a shared truth: patients benefit when systems work smoothly, consistently, and without unnecessary delay.
